Form 8-K - Current report:
SEC Accession No. 0000912282-14-000023
Filing Date
2014-01-16
Accepted
2014-01-16 16:34:22
Documents
6
Period of Report
2014-01-14
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 3.02: Unregistered Sales of Equity Securities
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 antriabio8k_01142014.htm 8-K 42436
2 FORM OF NOTE ex4_1.htm EX-4.1 76791
3 FORM OF WARRANT ex4_2.htm EX-4.2 93587
4 FORM OF SUBSCRIPTION AGREEMENT ex10_1.htm EX-10.1 203778
5 PRESS RELEASE, DATED JANUARY 15, 2014 ex99_1.htm EX-99.1 13954
6 antriabiologo.jpg GRAPHIC 6720
  Complete submission text file 0000912282-14-000023.txt   441347
Mailing Address 890 SANTA CRUZ AVENUE MENLO PARK CA 94025
Business Address 890 SANTA CRUZ AVENUE MENLO PARK CA 94025 650-847-1919
AntriaBio, Inc. (Filer) CIK: 0001509261 (see all company filings)

EIN.: 273440894 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-54495 | Film No.: 14532421
SIC: 2834 Pharmaceutical Preparations